Page last updated: 2024-11-05

thiotepa and Brill-Symmers Disease

thiotepa has been researched along with Brill-Symmers Disease in 2 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fenske, TS1
Kahl, BS1
Eickhoff, J1
Mitchell, TL1
Smith, EP1
Atkinson, E1
McCoy, AG1
Eckstein, L1
Flynn, B1
McMannes, J1
Howard, S1
Longo, WL1
Tarella, C1
Zanni, M1
Magni, M1
Benedetti, F1
Patti, C1
Barbui, T1
Pileri, A1
Boccadoro, M1
Ciceri, F1
Gallamini, A1
Cortelazzo, S1
Majolino, I1
Mirto, S1
Corradini, P1
Passera, R1
Pizzolo, G1
Gianni, AM1
Rambaldi, A1

Other Studies

2 other studies available for thiotepa and Brill-Symmers Disease

ArticleYear
Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:10

    Topics: Adult; Aged; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cel

2005
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jul-01, Volume: 26, Issue:19

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas

2008